Studies on ovarian and endometrial carcinoma have reported two patterns related to TP53 mutation–associated aberrant p53 staining: diffusely strong nuclear reactivity and complete absence of staining [26, 27]. This evidence concerns the gene TP53 and endometrial carcinoma.